Form 8-K - Current report:
SEC Accession No. 0001279569-24-000091
Filing Date
2024-02-01
Accepted
2024-01-31 18:05:39
Documents
17
Period of Report
2024-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K fourfront8k.htm   iXBRL 8-K 31779
2 SECOND AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT DATED JANUA ex101.htm EX-10.1 60688
3 NEWS RELEASE DATED JANUARY 31, 2024 ex991.htm EX-99.1 9373
4 GRAPHIC logo.jpg GRAPHIC 8404
  Complete submission text file 0001279569-24-000091.txt   301418

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20240129.xsd EX-101.SCH 3036
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20240129_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20240129_pre.xml EX-101.PRE 22372
19 EXTRACTED XBRL INSTANCE DOCUMENT fourfront8k_htm.xml XML 3406
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 24584266
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)